Arginine vasopressin (AVP) is a hormone synthesized from the hypothalamus in response to increased plasma osmotic pressure and decreased blood volume

which influences glucolipid metabolism by binding to AVP receptors. Recent studies show that Copeptin

co-secreted with AVP in equimolar amounts

is considered stabilized

sensitive and not bioactive surrogate marker of AVP. Elevated plasma levels of Copeptin are essentially associated with diabetes

diabetic complications

obesity

insulin resistance

hyper-tension

hyperlipidemia

non-alcoholic fatty liver disease and other metabolic diseases. Therefore

exploring the relationship between Copeptin and metabolic diseases actively will contribute to the early diagnosis of related diseases.